⌕
Alkermes · ALKS · Nasdaq
Tenet 37 · Weak
Compare
$46.53−1.06%At closeTenet 37 · Weak
$46.53−0.50 (−1.06%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Alkermes (ALKS) Earnings Forecast

Analysts expect Alkermes (ALKS) to lose $0.53 a share in FY26, the average of 9 estimates as of Nov 13, 2026.

Sources Analyst estimates EstimatesConsensus as of How we compute thisNot investment advice

2 figures withheld by our checks. Each blank figure names its reason.

FY26 consensus EPS
$−0.53
9 analysts
FY27 consensus EPS
$0.57
8 analysts · low $−1.37, high $2.22
EPS revisions, 30 days
+1.1%
$−0.53 to $−0.53
Disagreement, FY26
$0.26
wide, $−0.60 to $−0.33

Consensus estimates only. Analysts' price forecasts and ratings are not licensed here.

Consensus as of Nov 13, 2026 · we check it nightly

Analysts expect Alkermes to earn $3.00 a share in FY30; 4 analysts publish an estimate for FY30.

Forward P/E · FY26E
—
$47.03 (as of close, Nov 13, 2026) ÷ $−0.53 consensus EPS
Coverage · FY26
9 · 14
EPS estimates · revenue estimates

Are estimates going up or down lately?

The FY26 EPS consensus is $−0.53, a loss that widened 10.1% in 91 days. Every figure compares one fiscal period at both ends.

EPS consensus, change over the last 91 days. One step per nightly change.

−25.5%−10.8%+4.0%FY26 −10.1%FY27 −15.6%Aug 15Nov 13
EPS30 days90 daysshown aboveSince Jul 9
FY269 analysts▲ +1.1%$−0.53 to $−0.53▼ −10.1%$−0.48 to $−0.53▼ −37.3%$−0.38 to $−0.53
FY278 analysts▲ +7.5%$0.54 to $0.57▼ −15.6%$0.68 to $0.57▲ +1.2%$0.57 to $0.57
Sep '264 analysts▼ −3.7%$−0.08 to $−0.08▼ −113.0%$−0.04 to $−0.08▼ −1000.8%$0.01 to $−0.08
Dec '264 analysts▼ −143.8%$−0.09 to $−0.22▼ −236.9%$−0.06 to $−0.22▼ −236.9%$−0.06 to $−0.22

Contributors at both ends of the window: FY26 8 and 9. A change in the average can come from a new contributor as much as from a changed mind, so both counts stay in view.

Measured between two of our own nightly snapshots of one fiscal period, so a new fiscal year entering the view is never read as a revision. Never backfilled. A window still filling says how many days it holds; a blank one means our record is not that long yet.

If the Street is right, what does that imply for the share price?

Price as of close, Nov 13, 2026 · consensus as of Nov 13, 2026

At 43.7 times earnings, its average over the last five fiscal years, the FY28 consensus of $0.99 works out to $43 a share.

Consensus EPS · FY28
$0.99
11 analysts · low $−0.46, high $2.70 · thin coverage
Multiple · five-year average P/E
43.7×
Average of the fiscal-year P/Es, FY12 to FY25.
×
Receipt · ALKS · FY28Nov 13, 2026
Implied, a share
$43

Range on the low and high estimate: $−20 to $118.

$−20 low$118 high
0.99 × 43.7, to the dollar
Drag the multipleShaded: where Alkermes' P/E sat at each fiscal year end, FY12 to FY25. Each dot is one year.
11×20×30×40×50×60×
10-yr median 16.4×5-yr avg 43.7×$43 a share

Each point on the line is a multiple, and the flag is the price it implies for FY28. Past multiples are context, not a guide to future ones.

This is multiplication, not a forecast. It assumes the market pays the multiple you chose and that the consensus is right. Both are often wrong.

We hold no forward multiple for Alkermes today, so there is nothing here to set against the growth the Street expects.Show the multiple against its own recordHide the multiple record
Trailing P/E at each fiscal year end, FY12 to FY25 · over 4 fiscal years. The mark is the median of the last 4.
13.0× low129.1× high
16.4× median
We hold no trailing multiple for this company today, so nothing marks today on the track.

How much do analysts disagree?

For FY30, estimates run from $2.79 to $3.36 around an average of $3.00, drawn by 4 analysts.

FY26E9 analysts
$−0.60 to $−0.33 · $0.26 wide
FY27E8 analysts
$−1.37 to $2.22 · $3.59 wide
FY28E11 analysts
$−0.46 to $2.70 · $3.16 wide
FY29E4 analysts
$1.79 to $2.17 · $0.37 wide
FY30E4 analysts
$2.79 to $3.36 · $0.58 wide

The dashed line is FY25 filed $1.43, on the GAAP basis.

A wide spread is disagreement, not risk; a narrow one is agreement, not accuracy. Later years are always wider because fewer people forecast them. Bars in amber rest on fewer than 15 analysts. The tick on each bar is the average. Spreads are shown in currency rather than as percentages, because a percentage of a number near zero overstates it.

Is next quarter a high bar or an easy one?

Analysts expect Alkermes to lose $0.22 a share in the December quarter, the average of 4 estimates. Results are expected by Feb 16, 2027. Last quarter, which ended in September, Alkermes earned $0.49 a share. Analysts had expected $0.37, so it came in 32.9% higher.

0
$0.29
$−0.22high $−0.14
low $−0.26
−174.7%crosses bases
Dec 2025 quarterfiled · GAAPDec 2026 quarterconsensus · Street basis · 4 analysts
Expected report
Feb 16, 2027
Expected by Feb 16. An estimate, not a date the company has set. Companies move it.
Revenue expected · December quarter
$461.6M
11 analysts, 444.0 to 470.5 in $M · 384.5 in the same quarter a year ago

The step from a filed quarter to a consensus crosses bases: the filed figure is the company's own GAAP number and the consensus is on the Street's basis. It is printed with both bases named, not as growth. Last quarter's comparison is measured against the last estimate we hold for that quarter rather than the one from the night before the report, because the nearest estimate we hold for it was recorded after the company had already reported. For the March quarter, analysts expect a loss of $0.04 a share.

Does Alkermes usually beat or miss?

So far we have checked 5 quarters, of which 4 came in above the estimate we held. We add a quarter to this record each time Alkermes reports. The next report is expected by Feb 16, 2027.

We started recording estimates on Jul 9, 2026, so quarters that reported before that date cannot be checked.

Our record, one quarter per report
+54.2%
Dec '23reaction
+16.3%
−64.0%
Mar '24reaction
−2.2%
Jun '24left out · adjusted
Sep '24left out · adjusted
+14.1%
Dec '24reaction
+1.0%
Mar '25left out · adjusted
+36.8%
Jun '25reaction
+3.3%
+32.9%
Sep '25reaction
−1.1%
Dec '25left out · adjusted
Mar '26left out
Jun '26left out
Sep '26left out
reportsFeb 16
Dec '26
Checked so far
5 quarters
one more every report
Beat expectations
4 of 5
full details on the Earnings tab
Share price reaction
+2.6%
the average over all 5 checked quarters, one session each, timed to each release
Typical gap vs estimate
+32.9%
shown once 4 quarters are checked

Checked against the company's reported figure (GAAP) and the average estimate we recorded the night before its results release. Where analysts' number is on an adjusted basis, we leave the comparison out rather than force it. We started recording estimates for Alkermes on Jul 9, 2026, so earlier quarters cannot be checked, and we never fill them in after the fact. Dec '23, Mar '24, Dec '24, Jun '25, Sep '25 are drawn hollow: we hold no estimate for those quarters recorded strictly before the report, so it is scored against the last estimate we hold rather than the night-before one.

The Street expects sales to grow 5.7% in FY27. Consensus EPS is a loss in FY26, so there is no EPS growth rate to take apart.

9 analysts publish an EPS estimate for FY26 and 14 publish revenue. Coverage thins with distance: 4 EPS estimates for FY30. Consensus figures are on the Street's basis and filed figures are GAAP; we label the gap, we do not explain it away.Show coverage by year and over timeHide the coverage chart
Analysts by fiscal year · outlined revenue, filled EPS. Amber marks a panel of fewer than 15.
149
FY26E
138
FY27E
1511
FY28E
104
FY29E
74
FY30E
The FY26 panel held 8 analysts when our record of it began on Jul 9, 2026 and holds 9 tonight.

The full consensus, year by year

Consensus as of Nov 13, 2026 · filed figures as reported
Revenue · $Bfiled · consensus average · band = low to high
1.02.02.9historyStreet forecastFY22FY25FY30E

Coverage thins with distance: 14 revenue estimates for FY26, 7 for FY30.

Diluted EPS · $filed · consensus average · band = low to high
−1.660.953.55historyStreet forecastFY22FY25FY30E

Out-year bands widen as fewer analysts publish: 9 EPS estimates for FY26, 4 for FY30.

Fiscal yearRevenue $BYoYEPS $YoYEBITDA $BNet inc. $BShares BAnalysts rev · EPSFwd P/E
FY25Filed1.5—1.43————as filedn/m
FY26E1.81.8 to 1.8▲23.9%a−0.53−0.60 to −0.33▼136.8%a−0.0−0.10.1514 · 9—
FY27E1.91.8 to 2.0▲5.7%0.57−1.37 to 2.22—0.50.30.5013 · 881.8×
FY28E2.11.9 to 2.7▲9.9%0.99−0.46 to 2.70▲72.4%0.70.40.4515 · 1147.4×
FY29E2.32.2 to 2.6▲9.9%1.931.79 to 2.17n/cb0.50.30.1710 · 424.4×
FY30E2.62.5 to 2.9▲12.3%3.002.79 to 3.36▲55.3%0.80.50.177 · 415.7×

Average estimate with low to high beneath. Amber counts mark thin coverage and thin rows carry an amber rule. Shares = consensus net income ÷ consensus EPS, a direction rather than a decimal. The filed row's last column is today's price over the last four reported quarters, the one trailing multiple in that column. a This step crosses the seam: last year is a filed GAAP actual and this year is a consensus estimate, so the two are not prepared on one basis. b More than a third of the analyst panel changed between these two years, so the difference of the two averages measures the panel rather than the forecast.

These are consensus estimates: what analysts expect the business to earn, not where they think the stock trades. Coverage thins and the low to high band widens in the out-years. Context, not advice.

Analysts' price forecasts and grades are not licensed here. This page shows forward consensus estimates only: 9 EPS estimates for FY26, 14 for revenue. Not investment advice.

What do analysts expect Alkermes to earn in FY26?

Analysts expect Alkermes to lose $0.53 a share in FY26, the average of 9 estimates as of Nov 13, 2026.

What is Alkermes' earnings forecast for FY27?

The FY27 consensus for Alkermes is $0.57 a share from 8 analysts, as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.